Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
This study is currently recruiting participants.
Study NCT00004495 Information provided by FDA Office of Orphan Products Development
First Received: October 18, 1999 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
End Stage Renal Disease
Hyperhomocysteinemia
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
More general conditions related to this trial
Amino Acid Metabolism, Inborn Errors
Genetic Diseases, Inborn
Kidney Failure
Metabolic Diseases
Metabolism, Inborn Errors
Renal Insufficiency
Renal Insufficiency, Chronic
Urologic Diseases
Interventions listed in this trial
cyanocobalamin
folic acid
pyridoxine
Additional drug interventions recognized in this trial
Hydroxocobalamin
Vitamin B 12
More general drug interventions related to this trial
Growth Substances
Hematinics
Hematologic Agents
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
FDA Office of Orphan Products Development
Georgetown University
Back to top of Main Content
